
Metronidazole
Metronidazole treats trichomoniasis, amebiasis and anaerobic bacterial infections. In a large trial in women with trichomoniasis, a 7-day course cleared infection more often than a single dose. The label says to avoid alcohol and propylene glycol during treatment and for at least three days after, and it can cause nerve and brain side effects.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with trichomoniasis, amebiasis or an anaerobic bacterial infection that their prescriber has decided needs metronidazole
Common dosing range
Depends on the infection: for trichomoniasis the labels list a 7-day course (for example Flagyl 375 mg capsules twice daily for 7 days) or, for generic tablets, a 2 g one-day treatment; amebiasis is 750 mg three times daily for 5 to 10 days. Your prescriber sets the dose
When to expect effects
Courses usually last 1 to 10 days; symptoms of many infections improve within days
Watch out for
Avoid alcohol and products containing propylene glycol during treatment and for at least three days afterward (label contraindication). Report numbness, tingling, unsteadiness, confusion or seizures right away
What is it
Metronidazole is a prescription nitroimidazole antibiotic and antiparasitic, sold as Flagyl and as generic tablets, and also given by IV. Taken by mouth, its labels cover trichomoniasis (a common sexually transmitted infection) in women and men, amebiasis (amebic dysentery and amebic liver abscess), and serious infections caused by anaerobic bacteria, such as some abdominal, gynecologic, skin, bone, brain and lung infections. The label carries a boxed warning because it caused cancer in mice and rats, and says to avoid unnecessary use. The interaction most people ask about is alcohol: the label says to avoid alcohol and products with propylene glycol during treatment and for at least three days afterward.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
trichomoniasis in women Good Evidence | Still infected at test of cure: 11 percent with 7 days vs 19 percent with a single dose | Non-pregnant, HIV-negative women with trichomoniasis | Infection cleared at a test 4 weeks after a 7-day course in most women |
Clostridioides difficile diarrhea (off-label) Good Evidence | Clinical success 72.7 percent with metronidazole vs 81.1 percent with vancomycin | Adults with C. difficile infection for whom a prescriber chooses metronidazole, for example when other options are unavailable | 10-day course |
trichomoniasis in women
- Effect
- Still infected at test of cure: 11 percent with 7 days vs 19 percent with a single dose
- Best fit
- Non-pregnant, HIV-negative women with trichomoniasis
- Time
- Infection cleared at a test 4 weeks after a 7-day course in most women
Clostridioides difficile diarrhea (off-label)
- Effect
- Clinical success 72.7 percent with metronidazole vs 81.1 percent with vancomycin
- Best fit
- Adults with C. difficile infection for whom a prescriber chooses metronidazole, for example when other options are unavailable
- Time
- 10-day course
Evidence for 2 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
trichomoniasis in women
Disease adjunctIn a US trial at three sexual health clinics, 623 non-pregnant, HIV-negative women with Trichomonas vaginalis were randomized to a single 2 g dose of metronidazole or 500 mg twice daily for 7 days. Four weeks after treatment, 11 percent of the 7-day group still tested positive versus 19 percent of the single-dose group (relative risk 0.55). Bacterial vaginosis did not change the result. The trial stopped early for funding reasons and was open-label. Generic tablet labels list both a one-day and a 7-day option, the Flagyl capsule label lists a 7-day course, and the labels advise treating sexual partners.
Bottom line: Clears trichomoniasis in most women, and a 7-day course worked better than a single dose.
Clostridioides difficile diarrhea (off-label)
Disease adjunctThis is an off-label use: C. difficile is not among the oral metronidazole label's indications. In two multinational randomized trials pooled together, clinical success (diarrhea resolved and no severe abdominal discomfort for more than 2 days in a row, including day 10) was 72.7 percent with metronidazole 375 mg four times daily for 10 days versus 81.1 percent with oral vancomycin, a statistically significant difference; in severe infection it was 66.3 versus 78.5 percent, a difference that was not statistically significant. So metronidazole worked in most patients but less well than vancomycin. A third study drug, tolevamer, did worse than both antibiotics.
Bottom line: Off-label for C. difficile, it helped most patients but less often than vancomycin.
How it works
How to take it
What to track
Bottom line: Finish the course exactly as prescribed and keep all alcohol out until at least three days after the last dose.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: metronidazole has been shown to be carcinogenic (to cause cancer) in mice and rats. The label says unnecessary use should be avoided and use should be reserved for the labeled conditions. Studies looking for cancer in infants exposed during pregnancy did not show a higher risk, though they had limited power.
Brain and nerve effects: encephalopathy (with unsteadiness, dizziness and slurred speech), peripheral neuropathy including optic neuropathy, seizures and aseptic meningitis. Brain symptoms are generally reversible within days to weeks after stopping.
Severe skin reactions (toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS and AGEP), which can be life threatening.
Severe, irreversible liver injury and fatal acute liver failure in people with Cockayne syndrome (a label contraindication).
QT prolongation, reported particularly when metronidazole was given with other drugs that can prolong the QT interval; mild drops in white blood cells, so the label recommends blood counts before and after repeat courses.
Who should avoid it
- People allergic to metronidazole or other nitroimidazoles (label contraindication)
- People who have taken disulfiram within the last two weeks (label contraindication: psychotic reactions)
- Anyone who cannot avoid alcohol or products containing propylene glycol during treatment and for at least three days after (listed under the label's contraindications)
- People with Cockayne syndrome (label contraindication)
- Women in the first trimester of pregnancy being treated for trichomoniasis (label contraindication)
Pregnancy & breastfeeding
Pregnancy: metronidazole crosses the placenta. For trichomoniasis the label lists use in the first trimester as a contraindication. It says there are no adequate and well-controlled studies, but published studies including more than 5,000 pregnant women, many with first-trimester exposure, mostly did not show a higher risk of birth defects or other adverse fetal outcomes; one study suggested a higher risk of cleft lip that was not confirmed. The generic tablet label adds that in pregnant patients for whom other treatment has been inadequate, the one-day 2 g treatment should not be used, because it gives higher blood levels that can reach the fetus. Breastfeeding: metronidazole is present in breast milk at levels similar to the mother's blood, and infant levels can approach treatment levels; the label says a nursing mother may choose to pump and discard milk during treatment and for 48 hours after the last dose.
Interactions
Alcohol is a label contraindication: the current Flagyl and generic metronidazole labels list it under contraindications and say alcohol and products containing propylene glycol should not be consumed during treatment and for at least three days after the last dose, because a disulfiram-like reaction (abdominal cramps, nausea, vomiting, headaches and flushing) may occur. Some mouthwashes and liquid medicines contain alcohol or propylene glycol, so ask your pharmacist which of your products do.
Psychotic reactions have been reported in people with alcohol use disorder taking metronidazole and disulfiram together. The label says not to give metronidazole to anyone who has taken disulfiram within the last two weeks.
Metronidazole has been reported to strengthen warfarin's effect and prolong prothrombin time. The label says prothrombin time and INR should be carefully monitored; tell whoever manages your blood thinner before you start.
In people stable on relatively high lithium doses, short courses of metronidazole have raised lithium levels and, in a few cases, caused lithium toxicity. The label says to check lithium and creatinine levels several days after starting metronidazole; your prescriber decides.
Antibiotics can kill the live bacteria in probiotic products, and in lab testing of marketed probiotics, bacterial strains were generally susceptible to most oral antibiotics, while yeast probiotics such as Saccharomyces boulardii were resistant. The published summaries of these lab studies do not give results for metronidazole specifically, and the metronidazole label says it acts against bacteria that live without oxygen and has no clinically relevant activity against bacteria that can grow with oxygen. The probiotic does not weaken the antibiotic; ask your pharmacist about timing.
Kefir's live microbes may be affected by an antibiotic. Unlike with ciprofloxacin or tetracyclines, there is no label warning about dairy calcium blocking metronidazole. In a randomized trial of 125 children aged 1 to 5 taking antibiotics, kefir did not prevent antibiotic-associated diarrhea (18 versus 21.9 percent with placebo). Ask your pharmacist about timing if you drink it.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
See all 1 Metronidazole interaction →Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
How long after metronidazole can I drink alcohol?⌄
The label says to avoid alcohol and products with propylene glycol during treatment and for at least three days after the last dose, because abdominal cramps, nausea, vomiting, headaches and flushing may occur. That includes alcohol in some mouthwashes and liquid medicines; ask your pharmacist which products to check.
Is the metronidazole and alcohol reaction real?⌄
The label treats it as real: alcohol during treatment and for at least three days after is listed as a contraindication, because cramps, nausea, vomiting, headaches and flushing may occur. One small double-blind study in 12 healthy men (6 given metronidazole) found no reaction, but its authors noted reactions may still occur in some people, and the label contraindication stands.
Can I take probiotics with metronidazole?⌄
Probiotics do not weaken metronidazole, but antibiotics can kill some of the live bacteria in probiotic products, while yeast probiotics such as Saccharomyces boulardii are resistant. No trial has set the best timing; ask your doctor or pharmacist.
Does dairy or kefir interfere with metronidazole?⌄
The metronidazole label does not warn about dairy, unlike the labels for ciprofloxacin and tetracyclines, and food does not change how much is absorbed. Kefir's live microbes may be affected by the antibiotic, and a trial found kefir did not prevent antibiotic-associated diarrhea.
Why does metronidazole leave a metallic taste?⌄
The label says a sharp, unpleasant metallic taste is not unusual. If you also notice a furry tongue or sore mouth, tell your prescriber, since yeast overgrowth can occur during treatment.
References by claim
Track Metronidazole with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
